CXCL5 is associated with the increased risk of coronary artery disease

Xiao-Zeng Wang1, Li-Wen Liu, Xiao-Mo Du

  • 1aDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang bDepartment of Cardiology, Cardiovascular Research Institute, the General Hospital of Shenyang, Military, Shenyang, Liaoning, China.

Coronary Artery Disease
|August 20, 2015
PubMed

Insights

Chemokine CXCL5 and its receptor CXCR2 are elevated in human atherosclerotic coronary arteries. A specific CXCL5 genetic variant may increase coronary artery disease (CAD) risk in Chinese Han individuals.

Area of Science:

  • Cardiovascular Research
  • Genetics
  • Molecular Biology

Background:

  • Coronary artery disease (CAD) poses a significant global health burden.
  • The role of specific chemokines and their genetic variations in CAD pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the expression of CXCL5 and CXCR2 in human atherosclerotic coronary arteries.
  • To determine the association between a CXCL5 genetic variant and CAD susceptibility in a Chinese Han population.

Main Methods:

  • Immunohistochemistry and western blotting were used to detect CXCL5 and CXCR2 expression in coronary arteries.
  • Polymerase chain reaction (PCR)-direct sequencing analyzed the CXCL5 variant association with CAD.
  • Plasma CXCL5 levels were measured in a case-control study.

Main Results:

  • CXCL5 and CXCR2 expression were significantly higher in atherosclerotic plaques compared to normal arteries, increasing with lesion severity.
  • A functional nonsynonymous variant (-156 G/C) in the CXCL5 promoter was associated with CAD.
  • Plasma CXCL5 levels were elevated in CAD patients, particularly in those carrying the C allele of the -156 G/C variant.

Conclusions:

  • CXCL5 and CXCR2 are enriched in human atherosclerotic coronary arteries.
  • The CXCL5 promoter -156 G/C variant, specifically the C allele, may represent a genetic risk factor and an independent predictor for CAD.
  • CXCL5 shows potential as a molecular marker and therapeutic target for CAD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
994
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
577
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
859
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
680
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
864